239 related articles for article (PubMed ID: 9691100)
1. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2.
Weinrauch Y; Abad C; Liang NS; Lowry SF; Weiss J
J Clin Invest; 1998 Aug; 102(3):633-8. PubMed ID: 9691100
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections.
Grönroos JO; Laine VJ; Nevalainen TJ
J Infect Dis; 2002 Jun; 185(12):1767-72. PubMed ID: 12085323
[TBL] [Abstract][Full Text] [Related]
3. Synergy between extracellular group IIA phospholipase A2 and phagocyte NADPH oxidase in digestion of phospholipids of Staphylococcus aureus ingested by human neutrophils.
Femling JK; Nauseef WM; Weiss JP
J Immunol; 2005 Oct; 175(7):4653-61. PubMed ID: 16177112
[TBL] [Abstract][Full Text] [Related]
4. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.
Weinrauch Y; Elsbach P; Madsen LM; Foreman A; Weiss J
J Clin Invest; 1996 Jan; 97(1):250-7. PubMed ID: 8550843
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro.
Huhtinen HT; Grönroos JO; Grönroos JM; Uksila J; Gelb MH; Nevalainen TJ; Laine VJ
APMIS; 2006 Feb; 114(2):127-30. PubMed ID: 16519749
[TBL] [Abstract][Full Text] [Related]
6. Protection by group II phospholipase A2 against Staphylococcus aureus.
Laine VJ; Grass DS; Nevalainen TJ
J Immunol; 1999 Jun; 162(12):7402-8. PubMed ID: 10358193
[TBL] [Abstract][Full Text] [Related]
7. Effect of D-alanylation of (lipo)teichoic acids of Staphylococcus aureus on host secretory phospholipase A2 action before and after phagocytosis by human neutrophils.
Hunt CL; Nauseef WM; Weiss JP
J Immunol; 2006 Apr; 176(8):4987-94. PubMed ID: 16585595
[TBL] [Abstract][Full Text] [Related]
8. Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria.
Foreman-Wykert AK; Weinrauch Y; Elsbach P; Weiss J
J Clin Invest; 1999 Mar; 103(5):715-21. PubMed ID: 10074489
[TBL] [Abstract][Full Text] [Related]
9. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.
Madsen LM; Inada M; Weiss J
Infect Immun; 1996 Jul; 64(7):2425-30. PubMed ID: 8698462
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil response of transgenic mice expressing human group IIA phospholipase A2 in bacterial infections.
Laine VJ; Rajamäki A; Grass DS; Nevalainen TJ
Scand J Immunol; 2000 Oct; 52(4):362-8. PubMed ID: 11013007
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase A(2) in rabbit tears: a host defense against Staphylococcus aureus.
Moreau JM; Girgis DO; Hume EB; Dajcs JJ; Austin MS; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2347-54. PubMed ID: 11527949
[TBL] [Abstract][Full Text] [Related]
12. Induction of the activation-related antigen CD69 on human eosinophils by type IIA phospholipase A2.
Urasaki T; Takasaki J; Nagasawa T; Ninomiya H
Inflamm Res; 2000 Apr; 49(4):177-83. PubMed ID: 10858018
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes.
Weiss J; Inada M; Elsbach P; Crowl RM
J Biol Chem; 1994 Oct; 269(42):26331-7. PubMed ID: 7929350
[TBL] [Abstract][Full Text] [Related]
14. Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases.
Wright GC; Weiss J; Kim KS; Verheij H; Elsbach P
J Clin Invest; 1990 Jun; 85(6):1925-35. PubMed ID: 2189895
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.
Dominiecki ME; Weiss J
Infect Immun; 1999 May; 67(5):2299-305. PubMed ID: 10225887
[TBL] [Abstract][Full Text] [Related]
16. The action of human and rabbit serum phospholipase A2 on Escherichia coli phospholipids.
Kaplan-Harris L; Weiss J; Mooney C; Beckerdite-Quagliata S; Elsbach P
J Lipid Res; 1980 Jul; 21(5):617-24. PubMed ID: 6995545
[TBL] [Abstract][Full Text] [Related]
17. Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection.
Laine VJ; Grass DS; Nevalainen TJ
Infect Immun; 2000 Jan; 68(1):87-92. PubMed ID: 10603372
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2).
Koduri RS; Grönroos JO; Laine VJ; Le Calvez C; Lambeau G; Nevalainen TJ; Gelb MH
J Biol Chem; 2002 Feb; 277(8):5849-57. PubMed ID: 11694541
[TBL] [Abstract][Full Text] [Related]
19. A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A.
Movert E; Wu Y; Lambeau G; Touqui L; Areschoug T
J Immunol; 2011 Dec; 187(12):6437-46. PubMed ID: 22075700
[TBL] [Abstract][Full Text] [Related]
20. Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition.
Leidy C; Linderoth L; Andresen TL; Mouritsen OG; Jørgensen K; Peters GH
Biophys J; 2006 May; 90(9):3165-75. PubMed ID: 16461407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
